← Back to Search

Behavioural Intervention

Smartphone Messaging Support for Smoking

N/A
Waitlist Available
Led By Johannes Thrul, PhD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the efficacy of CBT and mindfulness/ACT interventions to help young adults quit smoking in real-time.

Who is the study for?
This trial is for young adults in the U.S., aged 18-30, who can read English and want to quit smoking. They must have smoked over 100 cigarettes in their lifetime and currently smoke at least once on three days each week. Participants need to own a smartphone and plan to quit within the next month.
What is being tested?
The study tests if messages sent through smartphones using cognitive behavioral therapy (CBT) or Mindfulness/Acceptance and Commitment Therapy (ACT) help young adults stop smoking. It focuses on sending support during high-risk situations that trigger the urge to smoke.
What are the potential side effects?
Since this intervention involves only messaging support without any medication, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in cigarettes smoked per day in past week as assessed by a single item
Change in smoking urge as assessed by a single item
Secondary study objectives
Activity completion as assessed by a single item
Change in cigarettes smoked as assessed by a single item
Change in frequency and intensity of smoking urges as assessed by two items of the Mood and Physical Symptoms Scale (MPSS)
+11 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Micro-randomized trial groupExperimental Treatment1 Intervention
The micro-randomized trial will determine if CBT and Mindfulness/ACT messages are superior to control messages in reducing the primary outcome momentary smoking urges. Based on participants' training data collected in the initial 14 days of EMA monitoring, intervention messages will be delivered during time-periods and at high-risk locations for smoking. In the intervention phase, participants will be prompted to complete 3 geofence-triggered EMAs per day for a total of 30 days. Each EMA will be followed by an intervention message and the type of message (CBT, Mindfulness/ACT, control) will be randomly selected at each time point (within-subject randomization).
Group II: EMA-only control groupActive Control1 Intervention
A total of N=80 participants will be randomized into an EMA-only control group, parallel to the micro-randomized trial intervention group. This group will conduct 14-day EMA only training phase just like the micro-randomized trial group, but will not be switched over to the intervention phase after these initial 14 days. Instead, participants will continue the EMA-only data collection procedure for an additional 30-days (analogous to the 30-day intervention phase of the micro-randomized trial). During these 30 days, the EMA-only control group will continue to receive 3 randomly prompted EMA surveys per day and an additional 3 EMA surveys triggered by smoking reports.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smartphone-based intervention messages
2023
N/A
~10

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor
425 Previous Clinical Trials
2,127,087 Total Patients Enrolled
Johannes Thrul, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health
1 Previous Clinical Trials
8 Total Patients Enrolled

Media Library

Smartphone-based intervention messages (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05836103 — N/A
Smoking Research Study Groups: EMA-only control group, Micro-randomized trial group
Smoking Clinical Trial 2023: Smartphone-based intervention messages Highlights & Side Effects. Trial Name: NCT05836103 — N/A
Smartphone-based intervention messages (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05836103 — N/A
~107 spots leftby Jun 2025